Trial intelligence / Profile preview

Comparison of tadalafil and tamsulosin in male LUTS/BPH: randomized crossover study

jRCT1051200099Recruiting

Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of tadalafil and tamsulosin in benign prostatic hyperplasia (BPH) and Micturition disorder (2 arms). Primary endpoint: Change in IPSS at 12 weeks. Started Dec 2020; status: recruiting.

02

Drugs

tadalafiltamsulosin
03

Conditions

benign prostatic hyperplasia (BPH)Micturition disorder

Beyond the preview

Go deeper on jRCT1051200099.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051200099.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call